Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 476-482

  Dekker, A W ^a   van't Veer, M B ^a   Sizoo, W ^a   Haak, H L ^a   van der Lelie, J ^a   Ossenkoppele, G ^a   Huijgens, P C ^a   Schouten, H C ^a   Sonneveld, P ^a   Willemze, R ^a   Verdonck, L F ^a   van Putten, W L ^a   Lowenberg B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGING; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031019713     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.476     Document Type: Article

References (41)

1. Jacobs AD, Gale RP: Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. N Engl J Med 311:1219-1231, 1984
2. Hoelzer D, Gale RP: Acute lymphoblastic leukemia in adults: Recent progress, future directions. Semin Hematol 24:27-39, 1987
3. Hoelzer D, Thiel E, Löffler H, et al.: Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38-47, 1984
4. Gottlieb AJ, Weinberg V, Ellison RR, et al.: Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: A prospective randomized trial by Cancer and Leukemia Group B. Blood 64:267-274, 1984
5. Clarkson B, Ellis S, Little C, et al.: Acute lymphoblastic leukemia in adults. Semin Oncol 12:160-179, 1985
6. Linker CA, Levitt LJ, D'Donell M, et al.: Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69:1242-1248, 1987
7. Fiere D, Extra JM, David B, et al.: Treatment of 218 adult acute lymphoblastic leukemias. Semin Oncol 14:64-66, 1987 (suppl)
8. Rivera G, Aur R, Dahl GV, et al.: Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia. Cancer 45:1284-1288, 1980
9. Arlin ZA, Ahmed T, Mittelman A, et al.: A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia. J Clin Oncol 5:371-375, 1987
10. Stryckmans P, De Witte Th, Bitar N, et al.: Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia. Semin Oncol 14:67-72, 1987 (suppl)
11. Hiddemann W, Kreutzmann H, Straif K, et al.: High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. Semin Oncol 14:73-77, 1987 (suppl)
12. Hoelzer D, Thiel E, Löffler H, et al.: Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. Semin Oncol 14:92-97, 1987
13. Breithaupt H, Pralle H, Eckhardt T, et al.: Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C). Cancer 50:1248-1257, 1982
14. Morra E, Lazzarino M, Inverardi D, et al.: Systemic high-dose Ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. J Clin Oncol 4:1207-1211, 1986
15. van't Veer MB, van Putten WLJ, Verdonck LF, et al.: Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation. Ann Haematol 66:277-282, 1993
16. Champlin R, Gale RP: Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 73:2051-2066, 1989
17. Kantarjian HM: Adult acute lymphocytic leukemia: Critical review of current knowledge. Am J Med 97:176-184, 1994
18. Copelan EA, McGuire EA: The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85:1151-1168, 1995
19. Weiss M, Telford P, Kempin S, et al.: Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia. Leukemia 7:832-837, 1993
20. Hoelzer D: Therapy and prognostic factors in adult acute lymphoblastic leukaemia, in Caen J, Hershko C, Hirsh J, et al. (eds): Baillière's Clinical Haematology, International Practice and Research: Acute Lymphoblastic Leukaemia, vol 7:2. London, Baillière Tindall, 1994, pp 299-320
21. Larson RA, Dodge RK, Burns CP, et al.: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 85:2025-2037, 1995
22. Hussein KK, Dahlberg S, Head D, et al.: Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood 73:57-63, 1989
23. GIMEMA Cooperative Group: GIMEMA ALL 0183: A multicentric study on adult acute lymphoblastic leukaemia in Italy. Br J Haematol 71:377-386, 1989
24. Ellison RR, Mick R, Cuttner J, et al.: The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: A prospective randomized clinical trial by Cancer and Leukemia Group B. J Clin Oncol 9:2002-2015, 1991
25. Stryckmans P, De Witte Th, Marie JP, et al.: Therapy of adult ALL: Overview of 2 successive EORTC studies (ALL-2 & ALL-3). Leukemia 6:199-203, 1992 (suppl 2)
26. Durrant IJ, Richards SM: Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: Report from the Medical Research Council Working Party on Adult Leukaemia. Br J Haematol 85:84-92, 1993
27. Hoelzer D, Thiel E, Löffler H, et al.: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123-131, 1988
28. Hoelzer D, Thiel E, Ludwig WD, et al.: The German multicentric trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 6:175-177, 1992 (suppl 2)
29. Fière D, Lepage E, Sebban C, et al.: Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 11:1990-2001, 1993
30. Rohatiner AZS, Bassan B, Battista R, et al.: High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer 62:454-458, 1990
31. Kantarjian HM, Walters RS, Keating MJ, et al.: Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 8:994-1004, 1990
32. Cassileth PA, Andersen JW, Bennett JM, et al.: Adult acute lymphocytic leukemia: The Eastern Cooperative Oncology Group experience. Leukemia 6:178-181, 1992 (suppl 2)
33. Wernli M, Tichelli A, Von Fliedner V, et al.: Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: A pilot assessment. Br J Haematol 87:39-43, 1994
34. Linker CA, Levitt LJ, O'Donnell M, et al.: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 78:2814-2822, 1991
35. Boucheix C, David B, Sebban C, et al.: Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA87). Blood 84:1603-1612, 1994
36. Pui C-H, Hancock ML, Head DR, et al.: Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 82:889-894, 1993
37. Thomas X, Archimbaud E, Charrin C, et al.: CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia 9:249-253, 1995
38. Cortes J, O'Brien SM, Pierce S, et al.: The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 86:2091-2097, 1995
39. Cuttner J, Mick R, Budman DR, et al.: Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: A CALGB study. Leukemia 5:425-431, 1991
40. Rivera GK, Pinkel D, Simone JV, et al.: Treatment of acute lymphoblastic leukemia. N Engl J Med 329:1289-1295, 1993
41. Chessells JM, Bailey C, Richards SM: Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Lancet 345:143-148, 1995